Ефективність комбінованого гепатопротектора Форслів у лікуванні хронічних дифузних захворювань печінки

The article presents the results of a study of serum ala-nine aminotransferase levels in patients with chronic diffuse liver diseases on the background of combined hepatoprotector Forceliv application. According to the findings, a significant decrease of this indicator in all examined patients has been found, that confirms the efficiency of the above mentioned hepatoprotector.